Jackson Hole Capital Partners LLC Has $4.22 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Jackson Hole Capital Partners LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,344 shares of the healthcare conglomerate’s stock after selling 32 shares during the quarter. Jackson Hole Capital Partners LLC’s holdings in UnitedHealth Group were worth $4,221,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in UNH. Howard Capital Management Group LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth approximately $341,000. GSG Advisors LLC lifted its position in shares of UnitedHealth Group by 14.4% in the 3rd quarter. GSG Advisors LLC now owns 746 shares of the healthcare conglomerate’s stock worth $435,000 after acquiring an additional 94 shares during the period. Principal Financial Group Inc. raised its stake in UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after acquiring an additional 180,479 shares in the last quarter. Capital Performance Advisors LLP acquired a new position in UnitedHealth Group during the third quarter worth $91,000. Finally, AEGON ASSET MANAGEMENT UK Plc raised its stake in UnitedHealth Group by 0.9% during the third quarter. AEGON ASSET MANAGEMENT UK Plc now owns 84,382 shares of the healthcare conglomerate’s stock worth $49,323,000 after acquiring an additional 769 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of several recent research reports. Stephens raised their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. Wells Fargo & Company cut their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Barclays cut their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Up 1.2 %

NYSE:UNH opened at $493.35 on Friday. The firm has a market capitalization of $451.28 billion, a price-to-earnings ratio of 31.83, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock’s 50 day moving average price is $513.78 and its two-hundred day moving average price is $553.57. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the company posted $5.83 EPS. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.70%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.